Companies /Industrials

Emerson Electric Company

NYSE: EMR Specialty Industrial Machinery
$150.19
▲ $1.21 (+0.81%) today
Markets closed · 5:15pm ET

Q3 2025 Earnings

Reported Aug 6, 2025, 6:30am ET · SEC source
$1.52
Beat +0.48%
EPS · est. $1.51
$4.6B
Miss −1.19%
Revenue · est. $4.6B
−3.4%
Trailing market
EMR vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−12%−8%−4%0Aug 6Aug 7report 6:30am ETearnings+1.4%−5.3%
−12%−8%−4%0Aug 6Aug 7earnings+1.4%−5.3%
EMR −5.3%NASDAQ +1.4%
−5%0+5%+10%Aug 5Aug 13report 6:30am ETearnings+3.5%+3.1%
−5%0+5%+10%Aug 5Aug 13earnings+3.5%+3.1%
EMR +3.1%NASDAQ +3.5%
−4.72%
Day of report
−0.82%
Next session
+0.80%
One week
−0.90%
30 days

S&P 500 over the same 30 days: +2.54%.

Did EMR Beat Earnings? Q3 2025 Results

Emerson Electric delivered a mixed but largely solid fiscal third quarter, edging past earnings expectations while falling short on the top line as the industrial automation giant navigated a shifting demand landscape. Adjusted EPS of $1.52 beat the $1.51 consensus by 0.48%, growing 6% from the prior year's $1.43, while revenue of $4.55 billion came in 1.19% below estimates despite rising 4.0% year-over-year. The key driver behind the earnings strength was a dramatic improvement in profitability, with pretax earnings margin expanding 570 basis points to 16.1%, partly reflecting the absence of a $279 million loss on the Copeland note receivable that had burdened the year-ago quarter. The Intelligent Devices segment anchored the quarter with $3.13 billion in sales, while the Software and Control segment benefited from the fully completed AspenTech acquisition, with that unit's adjusted EBITA margin widening to 35.9%. Shares fell after management trimmed full-year sales growth guidance to approximately 3.5%, though the company raised its adjusted EPS outlook to approximately $6.00 and lifted free cash flow expectations to roughly $3.20 billion.

Key Takeaways
  • Positive momentum in key end markets
  • Strong underlying growth of 3% in the quarter
  • Final Control segment led growth with 7% reported sales increase
  • Control Systems & Software adjusted EBITA margin expanded to 35.9% from 33.3%
  • Pretax earnings margin expanded 570 basis points year-over-year
  • Reduced tariff expense exposure relative to prior expectations

“Emerson's solid third quarter results reflect our sustained momentum, delivering strong underlying growth, profitability and cash flow, which we expect to continue as we finish the fiscal year. We are experiencing positive momentum in key end markets, and our team's ability to execute in this dynamic environment demonstrates the resilience of our business model and our operational excellence.”

Emerson Electric CEO, on the earnings call

Forward Guidance & Outlook

For fiscal year 2025, Emerson updated guidance to approximately 3.5% net and underlying sales growth, reflecting updated pricing expectations as tariff expense exposure has reduced. GAAP EPS is expected to be approximately $4.08. Adjusted EPS guidance was raised to approximately $6.00, an increase versus the previous midpoint. Operating cash flow and free cash flow expectations increased to approximately $3.6B and $3.2B, respectively. For Q4 2025, the company expects 5.5%-6.5% reported net sales growth, 5%-6% underlying sales growth, GAAP EPS of $1.13-$1.17, and adjusted EPS of $1.58-$1.62. The company expects to return approximately $2.3B to shareholders through $1.1B of share repurchases and approximately $1.2B of dividends.

EMR YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$2.0B$4.0B$4.4B$4.6BRevenue$2.3B$2.4BGross Profit$796.0M$734.0MOperating Income$329.0M$586.0MNet Income
$0$2.0B$4.0BRevenueGross ProfitOperating IncomeNet Income

EMR Revenue by Segment

Intelligent Devices
Software & Systems
Final Control$1.1B+7.0%
Control Systems & Software$1.1B+4.0%
Measurement & Analytical$1.0B+3.0%
Sensors
Discrete Automation$649.0M+5.0%
Safety & Productivity$346.0M−1.0%

Figures from SEC filings and company reports. Not investment advice.